ASIA PACIFIC NEWBORN SCREENING MARKET ANALYSIS

Asia Pacific Newborn Screening Market, by Products Type (Hearing Screening Devices, Mass Spectrometer, Pulse Oximetry, and Assay Kits and Reagents), by Test Type (Phenylketonuria (PKU), Critical Congenital Heart Defect (CCHD), Hearing Screening, Sickle Cell Disease, Maple Syrup Urine Disease (MSUD), Thyroid Disorder, Biotinidase Deficiency (BTD), and Others), by End User (Hospitals, Maternity & Specialty Clinics, and Diagnostic Centers) and by Country (China, Japan, South Korea, ASEAN, India, Australia, and Rest of Asia Pacific) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Aug 2022
Code : CMI2546
Pages :193
Formats :
Excel and PDF
Industry : Clinical Diagnostic

Market News

Asia Pacific Newborn Screening Market: Key Developments

In June 2022, PerkinElmer Inc., global corporation focused in the business areas of diagnostics, life science research, food, environmental and industrial testing will host a three-day scientific event exploring the latest advances in newborn screening programs and related technologies. Organized around the theme of ‘Learn, Share and Develop,’ PerkinElmer’s Newborn Screening World View summit will feature more than 20 presentations from participants across 11 countries. Each day, presentations and Q&A sessions scheduled will focus on a different topic, which will include: Newborn screening around the world – discussions around new and expanding programs worldwide, and novel ways to overcome common challenges. Leading the newborn screening conversation – expert advice on optimizing workflow efficiencies, throughput and accuracy, as well as opportunities to expand newborn screening panels. The future of newborn screening – conversations around next generation sequencing, molecular screening and expanding screening techniques and ideas.